Search Results - "Scholl, Suzy M."

PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients by de la Rochefordiere, Anne, Kamal, Maud, Floquet, Anne, Thomas, Laurence, Petrow, Peter, Petit, Thierry, Pop, Marius, Fabbro, Michel, Kerr, Christine, Joly, Florence, Sevin, Emmanuel, Maillard, Sophie, Curé, Hervé, Weber, Béatrice, Brunaud, Claire, Minsat, Mathieu, Gonzague, Laurence, Berton-Rigaud, Dominique, Aumont, Maud, Gladieff, Laurence, Peignaux, Karine, Bernard, Virginie, Leroy, Quentin, Bieche, Ivan, Margogne, Audrey, Nadan, AnaTereza, Fourchotte, Virginie, Diallo, Alhassane, Asselain, Benard, Plancher, Corine, Armanet, Sébastien, Beuzeboc, Philippe, Scholl, Suzy M

“…EGFR is frequently overexpressed in cervical cancer, suggesting EGFR blockade as a promising treatment approach. Cetuximab, an anti EGFR antibody, used…”
Get full text

HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia by Samuels, Sanne, Marijne Heeren, A., Zijlmans, Henry J. M. A. A., Welters, Marij J. P., van den Berg, Joost H., Philips, Daisy, Kvistborg, Pia, Ehsan, Ilina, Scholl, Suzy M. E., Nuijen, Bastiaan, Schumacher, Ton N. M., van Beurden, Marc, Jordanova, Ekaterina S., Haanen, John B. A. G., van der Burg, Sjoerd H., Kenter, Gemma G.

“…Background Usual type vulvar intraepithelial neoplasia (uVIN) is caused by HPV, predominantly type 16. Several forms of HPV immunotherapy have been studied,…”
Get full text

Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer by Scholl, Suzy M, Beal, Jonas, de Koning, Leanne, Girard, Elodie, Popovic, Marina, de la Rochefordière, Anne, Lecuru, Fabrice, Fourchotte, Virginie, Ngo, Charlotte, Floquet, Anne, Berns, Els MJJ, Kenter, Gemma, Gestraud, Pierre, von der Leyen, Heiko, Lecerf, Charlotte, Puard, Vincent, Roman, Sergio Roman, Latouche, Aurelien, Kereszt, Attila, Balint, Balazs, Rouzier, Roman, Kamal, Maud

“…Cervical cancer (CC) remains a leading cause of gynaecological cancer-related mortality world wide and constitutes the third most common malignancy in women…”
Get full text

Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome by Chouchane-Mlik, Olfa, Oniga, Alexandra, Latouche, Aurélien, Halladjian, Maral, Kleine-Borgmann, Felix B, Gérardy, Jean-Jacques, Mittelbronn, Michel, Kamal, Maud, Scholl, Suzy M

“…Cervical cancer (CC) is a leading challenge in oncology worldwide, with high prevalence and mortality rates in young adults, most prominent in low to…”
Get full text

High Numbers of Differentiated Effector CD4 T Cells Are Found in Patients with Cancer and Correlate with Clinical Response after Neoadjuvant Therapy of Breast Cancer by PEGUILLET, Isabelle, MILDER, Maud, LOUIS, Delphine, VINCENT-SALOMON, Anne, DORVAL, Thierry, PIPERNO-NEUMANN, Sophie, SCHOLL, Suzy M, LANTZ, Olivier

“…CD4(+) T cells influence tumor immunity in complex ways that are not fully understood. In this study, we characterized a population of human differentiated…”
Get full text

Fundamental Principles of Raising an Antitumour Immune Response in Vivo: A Complex Model, a Case Report, and a Perspective by Scholl, Suzy M.

“…In preclinical model systems, the fundamental principles underlying a successful and durable anti-tumour immune response are well demonstrated. In clinical…”
Get full text

Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site by Kamal, Maud, Lameiras, Sonia, Deloger, Marc, Morel, Adeline, Vacher, Sophie, Lecerf, Charlotte, Dupain, Célia, Jeannot, Emmanuelle, Girard, Elodie, Baulande, Sylvain, Dubot, Coraline, Kenter, Gemma, Jordanova, Ekaterina S., Berns, Els M. J. J., Bataillon, Guillaume, Popovic, Marina, Rouzier, Roman, Cacheux, Wulfran, Le Tourneau, Christophe, Nicolas, Alain, Servant, Nicolas, Scholl, Suzy M., Bièche, Ivan

“…Background Cervical cancer (CC) remains a leading cause of gynaecological cancer-related mortality with infection by human papilloma virus (HPV) being the most…”
Get full text

Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site by Kamal, Maud, Lameiras, Sonia, Deloger, Marc, Morel, Adeline, Vacher, Sophie, Lecerf, Charlotte, Dupain, Célia, Jeannot, Emmanuelle, Girard, Elodie, Baulande, Sylvain, Dubot, Coraline, Kenter, Gemma, Jordanova, Ekaterina S., Berns, Els M. J. J., Bataillon, Guillaume, Popovic, Marina, Rouzier, Roman, Cacheux, Wulfran, Le Tourneau, Christophe, Nicolas, Alain, Servant, Nicolas, Scholl, Suzy M., Bièche, Ivan

Get full text

Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site by Kamal, Maud, Lameiras, Sonia, Deloger, Marc, Morel, Adeline, Vacher, Sophie, Lecerf, Charlotte, Dupain, Célia, Jeannot, Emmanuelle, Girard, Elodie, Baulande, Sylvain, Dubot, Coraline, Kenter, Gemma, Jordanova, Ekaterina S, Berns, Els M J J, Bataillon, Guillaume, Popovic, Marina, Rouzier, Roman, Cacheux, Wulfran, Le Tourneau, Christophe, Nicolas, Alain, Servant, Nicolas, Scholl, Suzy M, Bièche, Ivan, Lafanechère, Laurence

“…BACKGROUND: Cervical cancer (CC) remains a leading cause of gynaecological cancer-related mortality with infection by human papilloma virus (HPV) being the…”
Get full text

Abstract 1746: Rational molecular assessment and innovative drug selection (RAIDs): Paving the way to personalized medicine in cervical cancer by Koning, Leanne de, Ouine, Bérengère, Cartier, Aurélie, Berns, Els M., Ruigrok-Ritstier, Kirsten, Beaufort, Corine, Balint, Balazs, Kereszt, Attila, Kenter, Gemma, Samuels, Sanne, Jordanova, Ekaterina S., Jeannot, Emmanuelle, Leyen, Heiko von der, Popovic, Marina, Luscap-Rondof, Windy, Sibut, Vonick, Kamoun, Choumouss, Britto, Isabel, Rincon, Claudia, Hupé, Philippe, Kamal, Maud, Scholl, Suzy M.

“…Abstract Cervical cancer (CC) is the fourth most common cause of cancer deaths in women worldwide, for which prognostic and predictive biomarkers are largely…”
Get full text

Regression of high-grade cervical intraepithelial neoplasia with TG4001 targeted immunotherapy by Brun, Jean-Luc, MD, Dalstein, Véronique, PhD, Leveque, Jean, MD, PhD, Mathevet, Patrice, MD, PhD, Raulic, Patrick, MD, Baldauf, Jean-Jacques, MD, Scholl, Suzy, MD, Huynh, Bernard, MD, Douvier, Serge, MD, PhD, Riethmuller, Didier, MD, PhD, Clavel, Christine, PhD, Birembaut, Philippe, MD, PhD, Calenda, Valérie, PhD, Baudin, Martine, MD, PhD, Bory, Jean-Paul, MD

“…Objective We sought to evaluate the safety and efficacy of TG4001 in patients with human papillomavirus (HPV) 16–related cervical intraepithelial neoplasia…”
Get full text

Modulation of MHC class II transport and lysosome distribution by macrophage-colony stimulating factor in human dendritic cells derived from monocytes by Baron, C, Raposo, G, Scholl, S M, Bausinger, H, Tenza, D, Bohbot, A, Pouillart, P, Goud, B, Hanau, D, Salamero, J

“…The macrophage-colony stimulating factor (M-CSF) has been already shown to affect the function of dendritic cells (DC). Therefore, the differentiation of…”
Get full text